NCT02478879View on ClinicalTrials.gov

A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2015

Conditions
Postmenopausal Osteoporosis
Interventions
DRUG

ZP-PTH

Patch applied daily for 30 minutes, 14 days

DRUG

FORTEO

Subcutaneous injection administration daily for 14 days

Trial Locations (1)

32117

Covance Daytona Beach Clinical Research Unit, Daytona Beach

All Listed Sponsors
lead

Zosano Pharma Corporation

INDUSTRY

NCT02478879 - A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen | Biotech Hunter | Biotech Hunter